Sweden
· Delayed Price · Currency is SEK Hansa Biopharma AB Statistics
Total Valuation
STO:HNSA has a market cap or net worth of SEK 1.53 billion. The enterprise value is 2.20 billion.
| Market Cap | 1.53B |
| Enterprise Value | 2.20B |
Important Dates
The last earnings date was Friday, March 21, 2025.
| Earnings Date | Mar 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
STO:HNSA has 67.81 million shares outstanding. The number of shares has increased by 19.59% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 67.81M |
| Shares Change (YoY) | +19.59% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.75% |
| Owned by Institutions (%) | 17.38% |
| Float | 38.31M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.25 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.72 |
| EV / Sales | 12.84 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -3.26 |
Financial Position
The company has a current ratio of 2.29
| Current Ratio | 2.29 |
| Quick Ratio | 2.22 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.60 |
| Interest Coverage | -4.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -43.41% |
| Return on Invested Capital (ROIC) | -66.46% |
| Return on Capital Employed (ROCE) | -115.91% |
| Revenue Per Employee | 1.27M |
| Profits Per Employee | -5.98M |
| Employee Count | 135 |
| Asset Turnover | 0.19 |
| Inventory Turnover | 40.53 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.77% in the last 52 weeks. The beta is 1.55, so STO:HNSA's price volatility has been higher than the market average.
| Beta (5Y) | 1.55 |
| 52-Week Price Change | -23.77% |
| 50-Day Moving Average | 25.95 |
| 200-Day Moving Average | 36.51 |
| Relative Strength Index (RSI) | 39.95 |
| Average Volume (20 Days) | 152,395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, STO:HNSA had revenue of SEK 171.32 million and -807.24 million in losses. Loss per share was -12.85.
| Revenue | 171.32M |
| Gross Profit | 87.76M |
| Operating Income | -631.64M |
| Pretax Income | -804.21M |
| Net Income | -807.24M |
| EBITDA | -629.08M |
| EBIT | -631.64M |
| Loss Per Share | -12.85 |
Balance Sheet
The company has 405.28 million in cash and 1.08 billion in debt, giving a net cash position of -673.73 million or -9.93 per share.
| Cash & Cash Equivalents | 405.28M |
| Total Debt | 1.08B |
| Net Cash | -673.73M |
| Net Cash Per Share | -9.93 |
| Equity (Book Value) | -589.83M |
| Book Value Per Share | -8.70 |
| Working Capital | 329.74M |
Cash Flow
In the last 12 months, operating cash flow was -674.88 million and capital expenditures -116,000, giving a free cash flow of -675.00 million.
| Operating Cash Flow | -674.88M |
| Capital Expenditures | -116,000 |
| Free Cash Flow | -675.00M |
| FCF Per Share | -9.95 |
Margins
| Gross Margin | 51.23% |
| Operating Margin | -368.70% |
| Pretax Margin | -469.43% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
STO:HNSA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.59% |
| Shareholder Yield | -19.59% |
| Earnings Yield | -52.91% |
| FCF Yield | -44.24% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STO:HNSA has an Altman Z-Score of -8.07. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.07 |
| Piotroski F-Score | n/a |